Plasma Elevations of Tumor Necrosis Factor-Receptor-1 at Day 7 Postallogeneic Transplant Correlate with Graft-versus-Host Disease Severity and Overall Survival in Pediatric Patients
Carrie L. Kitko(Vanderbilt University Medical Center), John E. Levine(Icahn School of Medicine at Mount Sinai), Sophie Paczesny(MUSC Hollings Cancer Center), Sung Won Choi(University of Michigan), Raymond J. Hutchinson(Children's Hospital of Los Angeles), Gregory A. Yanik(University of Michigan), Thomas Braun(University of Michigan), James L.M. Ferrara(Tisch Hospital), Dawn Jones(University of Michigan), Joel Whitfield(University of Michigan)
Cited by 45
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458